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Abstract
In vivo imaging is a platform technology with the power to put function in its natural structural context. With the
drive to translate stem cell therapies into pre-clinical and clinical trials, early selection of the right imaging
techniques is paramount to success. There are many instances in regenerative medicine where the biological,
biochemical, and biomechanical mechanisms behind the proposed function of stem cell therapies can be
elucidated by appropriate imaging. Imaging techniques can be divided according to whether labels are used and
as to whether the imaging can be done in vivo. In vivo human imaging places additional restrictions on the
imaging tools that can be used. Microscopies and nanoscopies, especially those requiring fluorescent markers, have
made an extraordinary impact on discovery at the molecular and cellular level, but due to their very limited ability
to focus in the scattering tissues encountered for in vivo applications they are largely confined to superficial
imaging applications in research laboratories. Nanoscopy, which has tremendous benefits in resolution, is limited to
the near-field (e.g. near-field scanning optical microscope (NSNOM)) or to very high light intensity (e.g. stimulated
emission depletion (STED)) or to slow stochastic events (photo-activated localization microscopy (PALM) and
stochastic optical reconstruction microscopy (STORM)). In all cases, nanoscopy is limited to very superficial
applications. Imaging depth may be increased using multiphoton or coherence gating tricks. Scattering dominates
the limitation on imaging depth in most tissues and this can be mitigated by the application of optical clearing
techniques that can impose mild (e.g. topical application of glycerol) or severe (e.g. CLARITY) changes to the tissue
to be imaged. Progression of therapies through to clinical trials requires some thought as to the imaging and
sensing modalities that should be used. Smoother progression is facilitated by the use of comparable imaging
modalities throughout the discovery and trial phases, giving label-free techniques an advantage wherever they can
be used, although this is seldom considered in the early stages. In this paper, we will explore the techniques that
have found success in aiding discovery in stem cell therapies and try to predict the likely technologies best suited
to translation and future directions.
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Background
A well-chosen imaging technique provides a means to
produce high-impact discovery and validation data for the
translation of novel regenerative therapies, but choosing
the right imaging tool can be tricky and is too often biased
by familiarity. Hence we try to provide, in this paper, a
means to compare the best known imaging technologies
in terms of their capabilities and limitations for stem cell
research. Table 1 provides an overview of the optimal
stem cell tracking characteristics, the probes used to
achieve this, and the appropriate imaging modalities with
their advantages and disadvantages. The techniques are
discussed in more detail in the following paragraphs.
Main text
Overview of functional imaging for regenerative medicine
Functional imaging, especially when provided in its
structural context, provides a platform for all branches
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Table 1 An overview of the optimal stem cell tracking characteristics, the probes used to achieve this, and the appropriate imaging











Fluorescence Reporter genes (e.g. iRFP),
quantum dots, exogenous
probes (e.g. PKH26)
Requires genetic modification and excitation light, high
background due to autofluorescence, signal loss with cell
division, low depth of imaging, limited spatial resolution
FLI
Bioluminescence Reporter genes (e.g. fLuc) Requires genetic modification and exogenous substrate
administration
BLI
Photoacoustic Reporter genes (e.g. LacZ,
iRFP), endogenous labels
(e.g. Hb, melanin)





Radionuclide Reporter genes (e.g. hNIS),
99mTc, 111In, 18F FDG
Ionizing radiation, poor anatomical detail (but can be
combined with magnetic resonance or x-ray), radioactive
decay limits imaging time, cellular toxicity, may require
genetic modification, expensive
SPECT, PET
Electron density Gold nanoparticles Limited spatial/soft tissue resolution, ionizing, not
indicative of cell viability, expensive
x-ray, CT
Fluorescence As described above As described above FLI
Bioluminescence As described above As described above BLI
Photoacoustic As described above As described above PAI
High spatial resolution Magnetic
resonance






Echography Microbubbles, perfluorocarbons Low resolution, acoustic artefacts, subject to user bias US
Fluorescence As described above As described above FLI
Bioluminescence As described above As described above BLI
Photoacoustic As described above As described above PAI
Radionuclide As described above As described above SPECT, PET
High imaging depth Photoacoustic As described above As described above PAI
Echography As described above As described above US





Fluorescence Reporter genes (e.g. iRFP) As described above FLI
Bioluminescence As described above As described above BLI
Photoacoustic As described above As described above PAI
High anatomical detail Magnetic
resonance
As described above As described above MRI






Echography As described above As described above US
Magnetic
resonance
As described above As described above MRI
Fluorescence As described above As described above FLI
Bioluminescence As described above As described above BLI
Quantifiable signal Fluorescence As described above As described above FLI
Bioluminescence As described above As described above BLI
No cellular genetic
modification
Echography As described above As described above US
Radionuclide 99mTc, 111In, 18F FDG As described above SPECT, PET
BLI bioluminescence imaging, CT computed tomography, FLI fluorescence imaging, 18F FDG fluoro-2-deoxy-D-glucose, Hb haemoglobin, 111In indium, MRI magnetic
resonance imaging, PAI photoacoustic imaging, PET positron emission tomography, SPECT single photon emission computed tomography, 99mTc technetium,
US ultrasound
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of regenerative medicine research. The technology is
constantly being advanced to image faster, deeper, less
invasively, and more quantitatively, driving discovery of
both biological and clinical mechanisms. This article will
review some of the plethora of advances that have been
made in recent years in technologies that have enabled
discovery in the field of stem cell research. Topics such
as in vivo fluorescence imaging and the benefits of label-
free techniques such as optical coherence tomography
(OCT) and photoacoustic imaging (PAI) will be dis-
cussed, along with super resolution microscopy and
radionuclide imaging.
Stem cell imaging in regenerative medicine
Stem cells have the ability to undergo clonal expansion
and to differentiate into multiple cell types; adult stem
cells offer advantages over embryonic stem cells due to
their ease of isolation and lack of ethical issues [1]. Re-
generative medicine, or the use of stem cells as therap-
ies, consists of multi-disciplinary approaches with the
aim of restoring function to diseased tissues and organs.
Such cell-based therapies have been extensively investi-
gated as promising avenues of treatment for a host of
disease types, including, but not limited to, cardiac dis-
ease, diabetes and orthopaedics. For the current rate of
progress to be maintained, non-invasive and reprodu-
cible methods to monitor and assess stem cell integra-
tion and survival in disease models are of paramount
importance. Imaging techniques with high spatial and
temporal resolution will enable accurate tracking of
transplanted stem cells to disease loci in vivo over a long
period of time in pre-clinical (animal) models and, ul-
timately, in clinical trials. Information obtained from
such studies will also allow scientists and clinicians to
optimise stem cell administration regimens (e.g. dose,
route of administration, timing) and to assess the effi-
cacy of a cell-based treatment.
Currently, tracking stem cell migration and engraft-
ment is achieved using appropriate imaging systems in
parallel with endogenous and exogenous cell-labelling
methods. An ideal cellular label should:
 be biocompatible and non-toxic to cells;
 be quantifiable;
 be inexpensive;
 remain undiluted following cell division;
 not leak into adjacent non-transplanted cells;
 remain stable over long periods of time in vivo;
 not interfere with normal cell function;
 not require genetic modification or the injection of a
contrast agent.
Stem cells can be genetically modified to express re-
porter genes or proteins that can emit fluorescence/
bioluminescence (or other useful proteins such as lacZ
or NIS) or be treated to uptake exogenous contrast
agents, such as organic dyes, nanoparticles, radionu-
clides, or magnetic compounds [2].
In vivo fluorescence imaging
The collection of data from an innate biological site is
one of the largest advantages of in vivo imaging of any
form. Macroscopic imaging of either animal or human
sources, as opposed to the imaging of tissue explants or
cells from culture, encounters an array of complications.
In vivo fluorescence imaging is similar to conventional
fluorescence microscopy in that high-end low-light cam-
eras are used to detect an emission signal generated
from a fluorophore or probe [3, 4]. In recent years, the
development of stem cell therapies for treatment of a
vast array of diseases has progressed rapidly [5]. Molecu-
lar tagging and the addition of probes to monitor, track,
and assess the administered cells in a non-invasive man-
ner in vivo, in both animal and human clinical studies,
will be discussed in this section. Further to this, the use
of multimodal approaches (fluorescence in conjunction
with bioluminescence and high-resolution imaging tech-
niques) will be briefly highlighted.
Ex vivo histopathological analysis of modified stem cell
behaviour was traditionally carried out, using fluorescent
probes, on excised biopsies from animal model studies.
These examinations were incapable of providing real-
time information about alterations to the tissues under
study. Despite this limitation, these probes provided the
framework for many of the newer generations of
markers currently in use today to be developed and re-
fined. The incorporation of reporter genes into cellular
machinery has provided scientists with a method to visu-
alise cells, via fluorescent modifications, to a depth of
about 2 mm into the tissue. The incorporation of these
genes into a cell is referred to as indirect labelling. Re-
porter genes allow the monitoring of physiologically
relevant biological processes as they occur in situ. Trad-
itionally, green fluorescent protein (GFP) tags were used
in fluorescence imaging to identify cells [6]. The main
advantage of this form of labelling is that expression of
the functional reporter probe only occurs after the cell
has transcribed the gene of interest and the mRNA is
translated into the modified version of the protein and a
biosensor is created. This allows direct correlations to be
drawn between the levels of expression of the probe and
cell viability. The expression of the modified gene is
propagated to future generations of cells and, in this
way, the longevity of this method is preferable in an in
vivo scenario as it would potentially create a long-term
reporter of cell stem functionality and enable tracking/
tracing over a lengthier period of time. Genetic modifi-
cation of cells, via transfection (non-viral vectors) or
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transduction (viral vectors), that are employed in order
to allow the incorporation of these reporter genes is, at
present, the major limiting factor of this technique [7].
The long-term safety of incorporating transformed gen-
etic material and the potential for immune responses or
tumour development in recipients of these therapies re-
quires further investigation and regulation at a clinical
trial level. With a strong focus on safety and therapeutic
efficacy for stem cell delivery, many laboratories are de-
veloping alternative methods to allow the integration of
reporters into the cellular genome [8]. Recent work has
focused on the development of fluorescent probes for in-
corporation in reporter genes amongst other uses. Fluor-
escent probes whose spectra are in the far red, towards
the near infrared (NIR) portions of the spectrum of light
(650–900 nm), are experimentally the most desirable for
scientists wishing to carry out in vivo imaging. The po-
tential for alterations to the physiological state of the cell
under study must be monitored when utilising any type
of fluorescence imaging technique. The benefits of im-
aging in this portion of the spectrum will be discussed in
later sections. Earlier probe variants including mKate,
with excitation and emission at 588 and 635 nm and
synthesised from the sea anemone Entacmaea quadrico-
lor, were developed for whole body imaging, and more
recently phytochrome (photosensor) from the bacteria
Deinococcus radiodurans has allowed production of the
IFP 1.4 marker [9, 10]. Despite these advances, quantum
yield for these probes remained poor. Newer probes in-
cluding iRFP (near-infrared fluorescent protein) are
aimed at increasing the fluorescence output and signal
intensity through modifications of these phytochromes,
and display improved pH and photo-stability in vivo
[11]. The use of optogenetics, or the control of bio-
logical processes in mammals (both cells and tissues)
by light, is emerging as a very powerful manipulation
technique. This method combines the genetic modifica-
tions discussed above, with the possible inclusion of
NIR probes, and the potential to act as a therapy medi-
ator for stem cell treatments [12, 13]. Work to date has
concentrated on mainly neural stem cells in animal
models [14, 15].
The combination of fluorescence, bioluminescence,
and high-resolution probes are referred to as multimodal
reporter probes. The combination of the best aspects of
all probes and techniques allows a much great amount
of data to be collected from one source. Recent work
from Roger Tsien’s group has shown that one of these
triple modality reporters has been implemented in an
in vivo animal study for qualitative tumour therapy and
efficacy of drug delivery [16]. The development and ad-
vancement in the engineering and construction of these
fluorescent and multimodal probes holds most hope for
successful deep tissue in vivo fluorescence imaging.
In summary, fluorescent imaging modalities are sim-
pler, cheaper, more user friendly, and convenient to carry
out than their higher resolution counterparts. The devel-
opment of high-sensitivity cameras, which are capable of
detecting very low levels of gene expression, and the
quantitatively close relationship between cell number
and fluorescence detection signals are all major benefits
of these techniques.
The advantages of label-free optical imaging techniques
Appropriate imaging modalities are needed for the
tracking of stem cells to investigate various biological
processes such as cell migration, engraftment, homing,
differentiation, and functions. The ideal modality for
tracking stem cells requires high sensitivity and high
spatial resolution, non-toxic imaging. Contrast agents
should be biocompatible and highly specific to reduce
perturbation of the target cells. The ideal modality
should provide non-invasive, depth-resolved imaging in
situ and be able to detect single cells, and should show a
difference between cell loss and cell proliferation. Cur-
rently none of the known imaging modalities has all of
these characteristics [17, 18].
In contrast to the above-mentioned modalities, this
section will focus on those techniques which do not em-
ploy the use of an endogenous/exogenous contrasting
agent. Label-free imaging techniques provide the unique
possibility to image and study cells in their natural
environment.
For example, such techniques can be used for the iso-
lation of human pluripotent stem cells (hPSCs), enriched
to 95–99 % purity with >80 % survival, and to keep nor-
mal transcriptional profiles, differentiation potential, and
karyotypes [19]. Well-known label-free imaging modal-
ities, such as quantitative phase microscopy (QPM), are
used to reconstruct nanoscale phase information within
cells, including living cells [20]. Interference reflection
microscopy (IRM), also sometimes referred to as Inter-
ference Reflection Contrast, or Surface Contrast Micros-
copy, is often used in conjunction with QPM [21]. This
non-invasive label-free technique is employed in the
study of cellular adhesions, migration, cell mitosis, and
cytotoxicity amongst other parameters in stem cell cul-
tures such as human induced pluripotent stem cells
(hIPSCs). Greyscale images are created from the slight
variations generated in optical path differences where
reflected light is used to visualise structures which are
at, or near, a glass coverslip surface [22]. This technique
can provide quantitative information on the intracellular
cytoplasmic and nuclear alterations often required by
scientists whilst assessing stem cells and their differenti-
ation state in culture, and therefore assist in the screen-
ing selection of hIPSC colonies [21]. Optical diffraction
tomography permits three-dimensional (3D) image
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reconstruction of a single cell [23–25]. The oblique-
incidence reflectivity difference (OI-RD) microscope was
proposed for label-free, real-time detection of cell sur-
face markers and applied to analyse stage-specific em-
bryonic antigen 1 (SSEA1) on stem cells in the native
state [26]. Another imaging modality, digital holographic
microscopy (DHM), provides the possibility for imaging
of a 3D volume with a single exposure which is very use-
ful for imaging of living cells. DHM was combined with
light scattering angular spectroscopy to provide spatially
resolved quantitative morphological information [27–29],
improved resolution via a synthetic aperture approach
[30–32], and used for 3D tomographic imaging [33]. The
disadvantages of these techniques are that they are not
depth-resolved and cannot be applied to highly scattered
media like tissue, or they are too slow and not suitable
for in vivo applications.
The recently developed spectral encoding of the spatial
frequency (SESF) approach provides the means for label-
free visualization of the internal submicron structure in
real time with nanoscale sensitivity [34, 35], which could
be a good alternative for in vivo stem cell investigation.
Precise characterisation of the internal structure with
nanoscale accuracy and sensitivity can be performed
using the spectral distribution of scattered light to re-
construct the nanoscale structural characteristics for
each pixel [36]. The theoretical basis for tomographic
imaging with increased spatial resolution and depth-
resolved characterization of the 3D structure has been
established [37]. Label-free, depth-resolved structural
characterization of highly scattering media (tissue, skin)
with nanoscale sensitivity, based on the SESF approach,
has been proposed [38, 39]. Label-free, super-resolution
imaging using the SESF approach has been demon-
strated recently [40]. The parallel development of label-
free imaging techniques and the use of new non-toxic
contrast agents are very encouraging.
Optical coherence tomography for study of the stem cells
OCT is one of the promising techniques for depth-
resolved imaging of biomedical objects. OCT, developed
in 1991 by Fujimoto and co-workers at Massachusetts
Institute of Technology [41], can be considered as an
optical analogue of the ultrasound technique. In com-
parison with ultrasound, OCT provides improved reso-
lution of depth-resolved images to microscale, but the
penetration depth is limited. OCT can provide unique
depth-resolved morphologic and functional information.
For example, OCT facilitates cellular level structural and
functional imaging of living animals and human tissues
[42–44], performs vibration measurements in the retina
and ear at the nanoscale [45, 46], and depth-resolved
imaging of the cornea and mapping of vasculature
networks within human skin [47–51]. OCT has also
received much attention in the field of tissue engineering
[52–54]. In contrast to confocal microscopy, two-photon
microscopy, and other optical depth-resolved imaging
techniques, OCT provides a much better penetration
depth: about 2 mm in tissue instead of 100–500 mi-
crons. Recently, OCT (the standard spectral radar-OCT
(SR-OCT) system (Model OCP930SR; Thorlabs Inc.,
Newton, NJ, USA)) has been applied as a new imaging
strategy to investigate planarian regeneration in vivo in
real time [55]. The signal attenuation rates, intensity ra-
tios, and image texture features of the OCT images were
analysed to compare the primitive and regenerated tis-
sues, showing that they might provide useful biological
information regarding cell apoptosis and the formation
of a mass of new cells during planarian regeneration.
The spatial resolution of conventional OCT systems is
limited to about 10 microns and is insufficient for cell
imaging. Only some specific complicated systems—optical
coherence microscopes (OCMs; http://www.rle.mit.edu/
boib/research/optical-coherence-microscopy), such as high-
definition OCT (HD-OCT) and micro-OCT—provide
micrometre resolution in both transverse and axial direc-
tions in order to visualise individual cells (Skintell; Agfa
Healthcare, Mortsel, Belgium) [56]. This system uses a
two-dimensional, infrared-sensitive (1000–1700 nm) im-
aging array for light detection and enables focus tracking
along the depth of the sample. The movements of the
focal plane and the reference mirror are synchronised. As
a result, the lateral resolution is 3 μm at all depths of the
sample. Together with limited resolution, OCT provides
only limited molecular sensitivity. To solve the problem,
application of OCT for stem cell research is based on
using extrinsic contrast agents such as magnetic and iron
oxide particles, proteins, dyes, various types of gold nano-
particles, carbon nanotubes, and so forth. For example,
the first report to demonstrate the feasibility of photother-
mal optical coherence tomography (PT-OCT) to image
human mesenchymal stem cells (hMSCs) labelled with
single-walled carbon nanotubes (SWNTs) for in vitro cell
tracking in 3D scaffolds has been presented recently [57].
A photothermal BMmode scan was performed with exci-
tation laser driving with a frequency of 800 Hz. Figure 1a
shows the cross-sectional image of the combined struc-
tural and photothermal signal of the scaffold seeded with
SWNT-loaded MSCs with the photothermal excitation
laser turned on. Figure 1b shows the corresponding image
with the excitation laser turned off. It was shown that PT-
OCT imaging together with the SWNT nanoprobes looks
promising for visualising and tracking of MSCs in vitro
and in vivo.
Another possibility is multimodal imaging, which may
minimise the potential drawbacks of using each imaging
modality alone [17], such as the combination of OCT
and other imaging techniques (confocal microscopy,
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dielectric spectroscopy (DS), fluorescence microscopy,
and so forth) [56–60]. Bagnaninchi [58] used a spectral
domain optical coherence tomography (SDOCT) com-
bined with DS to qualitatively assess adipose-derived
stem cells loaded in 3D carriers. The broadband (from
20 MHz to 1 GHz) DS spectra were acquired at high cell
concentration simultaneously with 3D OCT imaging.
Chen et al. [59] used high-resolution OCT to visualise
the microstructures of the engineered tissue scaffolds in
3D and to investigate the key morphological parameters
for macroporous scaffolds, while fluorescence imaging
was conducted to monitor the population of labelled
hMSCs loaded on to the surface of the scaffolds. Ksan-
der et al. [60] used confocal microscopy, multiphoton
microscopy and OCT to study the conditions for limbal
stem cell maintenance, and corneal development and re-
pair. Lathrop et al. [61] showed, using a combination of
OCT and confocal microscopy, that OCT successfully
identified the limbal palisades of Vogt that constitute the
corneal epithelial stem cell niche, and offered the poten-
tial to assess and intervene in the progression of stem
cell depletion by monitoring changes in the structure of
the palisades. Schwartz et al. [62] used SDOCT together
with visual field testing, slit-lamp biomicroscopy, oph-
thalmoscopy, fluorescein angiography, autofluorescence
imaging, fundus photography, and electroretinography
to study human embryonic stem cell-derived retinal
pigment epithelium in patients with age-related macular
degeneration and Stargardt’s macular dystrophy. The re-
sults provide evidence of the medium- to long-term
safety, graft survival, and possible biological activity of
pluripotent stem cell progeny in individuals with any
disease, and suggest that human embryonic stem-
derived cells could provide a potentially safe new source
of cells for the treatment of various unmet medical dis-
orders requiring tissue repair or replacement.
A potential alternative to using contrast agents is the
recently developed nano-sensitive OCT which increases
sensitivity to structural alterations in space and in time
by more than 100 times [38, 39].
Optical coherence phase microscope
In 2011, Bagnaninchi’s group demonstrated that live
stem cells could be differentiated from their surrounding
environment by mapping the optical phase fluctuations
resulting from cellular viability and associated cellular
and intracellular motility with an optical coherence
phase microscope (OCPM) [63], an OCT modality that
has been shown to be sensitive to nanometer-level fluc-
tuations. In subsequent studies [64, 65], they examined
murine pre-osteoblasts and human adipose-derived stem
cells growing within two distinct polymeric constructs:
1) a 3D printed poly(D,L-lactic-co-glycolic acid) fibrous
scaffold; and 2) hydrogel sponges (alginate). In addition
to providing cell viability information, the endogenous
contrast between cells and scaffolds generated by cellular
motility enabled real-time, label-free monitoring of 3D
engineered tissue development [65].
Photoacoustic imaging
PAI (less often called optoacoustic imaging) is an emer-
ging biomedical imaging technique that exploits laser
generated ultrasound (US) waves to generate 3D images
of soft tissues. Tissue is exposed to pulsed nanosecond
laser light, resulting in localised heating of the tissue.
The increase in temperature of few degrees milliKelvin
causes transient thermoelastic tissue expansion which
generates broadband (MHz) pressure waves. The ultra-
sonic waves created are then detected using wideband
transducers and further converted into images. PAI is a
hybrid imaging modality that combines the high contrast
and spectroscopic-based specificity of optical imaging
with the high spatial resolution of US imaging [66]. It
provides an integrated platform for functional and struc-
tural imaging, which is suitable for clinical translation.
PAI breaks through the optical diffusion limit [67] and
provides real-time images with relatively high spatial
resolution, without ionizing radiation being involved.
The key advantages of the PAI technique over other im-
aging modalities include:
 the detection of haemoglobin, lipids, water, and
other light absorbing molecules with higher
penetration depth than pure optical imaging
techniques;
Fig. 1 a Combined structural and photothermal image of the
scaffold seeded with SWNT-loaded MSCs with the laser turned on.
b Combined structural and photothermal image of the scaffold
seeded with SWNT-loaded MSCs with the laser turned off
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 the ability to provide tissue information using an
endogenous contrast alone [68];
 the imaging of optical absorption with 100 %
sensitivity, which is two times greater than those of
OCT and confocal microscopy;
 unlike ultrasonography and OCT, it is speckle-free [69]
and provides inherently background-free detection.
The development of PAI techniques continues to be of
substantial interest for clinical imaging applications in on-
cology, including screening, diagnosis, treatment planning,
and therapy monitoring [70, 71]. PAI-based routines have
also been extensively used in accurate determination of
metabolic rate during early diagnosis and treatment of
various skin and subcutaneous tissue disorders. The other
potential implications of PAI encompass the domains of
dermatology [72, 73], cardiology [74, 75], vascular biology
[76, 77], gastroenterology [78, 79], neurology [80–82], and
ophthalmology [83, 84]. Figure 2 summarises the potential
clinical applications of PAI.
In PAI, stem cells are typically labelled using biocom-
patible materials with optical properties such as gold
(Au) nanoparticles (NPs) or Au nanorods (NRs). In a re-
cent study, hMSCs were labelled with 20-nm Au NPs
before their incorporation into PEGylated fibrin gel [85].
After injecting the fibrin gel intramuscularly into the lat-
eral gastrocnemius (lower limb) of an anaesthetised Lewis
rat, PAI was performed to visualise the in vivo neovascu-
larisation and differentiation of hMSCs.
Au NRs have plasmon resonance absorption and scat-
tering in the NIR region, which makes them attractive
probes for PAI [86]. In another study, hMSCs were la-
belled and imaged by silica-coated Au NRs (SiGNRs) [87].
The researchers found that the cellular uptake of SiGNRs
can be dramatically increased (fivefold) by silica coating
without changing function and viability of hMSCs.
Microcirculation imaging
Several techniques, including OCT and PAI, can be used
to image microcirculatory function. The microcirculation
is the usual route for delivery of stem cells by systemic or
local intravascular injection. It is also affected by the stem
cell therapies which may stimulate or suppress angiogen-
esis and will often have a major role in regeneration. In
addition to the 3D techniques discussed in detail here,
several other techniques are available to investigate the
microcirculatory response to stem cell therapy, e.g. laser
doppler, laser speckle, tissue viability imaging (TiVi), and
side stream dark field microscopy [88].
Confocal reflectance microscopy
Confocal reflectance microscopy employs innate alter-
ations in the refractive index of biological samples to
create contrast within an image. Intracellular organelles
and protein-protein interactions between these compo-
nents, or even the interface between two different cell
types as would be evident in an epithelial stromal inter-
face, would contribute to contrast variation [89]. In
recent years this technique has been used to non-
invasively study skin biopsies, myelinated axons, and
gather information from the excised bone marrow stem
cell niche [90–92]. A combination of both fluorescent
and reflectance images can be captured through the in-
stallation of a beam splitter into the light path, which al-
lows reflected light from the sample to pass into the
detection unit. In highly scattering tissues, like skin, the
advantages of confocal microscopy can be combined
with OCT techniques to produce the optical coherence
microscope (OCM). In this way, higher numerical aper-
ture lenses and coherence gating allows the collection of
clearer images through a greater depth in tissues, when
compared to either OCT or reflectance confocal modal-
ities alone [93].
Super-resolution microscopy (nanoscopy)
Sub-cellular imaging, for example of organelles, requires
diffraction-unlimited ‘super-resolution’ techniques. True
super-resolution is only achievable with near-field
optical techniques such as near-field scanning optical
microscopy and 4π microscopy. However, mainstream
Fig. 2 An overview of potential clinical applications of PAI
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functional super-resolution microscopy or nanoscopy
uses the ability to switch fluorescent molecules on and
off in a spot size smaller than the Abbé limit to over-
come the diffraction limit for image resolution. Fluores-
cent molecules become “bleached” for some period of
time once they have emitted a fluorescent photon. In
stimulated emission depletion (STED), the illumination
(excitation) spot remains diffraction-limited, but a con-
centric de-excitation doughnut-shaped beam turns off
fluorescence in most of that spot [94]. Since the illumin-
ation wavelength is filtered out, only the longer fluores-
cent wavelength is detected or visible in the microscope.
Hence, the smaller the spot at the centre of the
doughnut which is allowed to fluoresce, the smaller the
spot which can be imaged. Thus, the technique gets
around the Abbé limit rather than breaks it. The size of
the spot which can be imaged is only limited by the in-
tensity of the doughnut-shaped beam. As this intensity
gets larger (GW/cm2 have been used), the size of the
spot from whence fluorescence can be emitted gets
smaller. STED and reversible saturable optical linear
fluorescence transitions (RESOLFT) nanoscopy has been
found especially useful for neurons or fixed cells and can
be used in fast processes [95].
Some other techniques like photo-activated localization
microscopy (PALM) and stochastic optical reconstruction
microscopy (STORM) tackle this problem statistically
[95]. These techniques find the locus of a molecule by fit-
ting a Gaussian profile to the emission. If enough pho-
tons are collected, the locus can be identified with an
uncertainty less than the diffraction limit. Conversely,
two molecules within the lateral optical resolution can
only be localised if the emitted photons occur at different
times. Thus, these techniques are more suited to slower
processes.
PALM, STORM, and STED share the need to switch
off molecules and are essentially limited to imaging
fluorophores or objects which are labelled with fluoro-
phores which are generally toxic. Nonetheless, there are
now well-established methods for labelling almost any-
thing (typically cells or cell components) with fluores-
cent molecules. They also share the further steps of
identification and localization [96]. Ultimately, of course,
they are limited by the size of the fluorescent molecule
and practical considerations such as the integrity, viabil-
ity, and drift of the sample. With samples bigger than an
individual cell, refractive index variations will cause dis-
tortions which are significant on the nanoscale.
Microcomputed tomography
We are all familiar with the extraordinary imaging
capabilities of x-ray computed tomography (CT) in the
hospital. However, the resolution is limited to approxi-
mately 1 mm in favour of penetration depth of tens of
centimetres. With higher x-ray dose per voxel, the signal
to noise ratio can be sufficient to achieve sub-micron
resolution in engineering materials after several hours, al-
though this dose would be too great for living cells and
tissues. In vivo microCT uses a small sample bore typically
sufficient for a mouse and can generate exquisite struc-
tural images with approximately 100-μm resolution in all
directions. MicroCT application to stem cell research has
already been reviewed by Boerckel et al. in this series [97].
Radionuclide imaging
Adding the functional capabilities provided by positron
emission tomography (PET), PET-CT, and single-photon
emission computed tomography (SPECT) imaging al-
lows the stem cell functions to be put in their proper
structural context. The earliest studies utilising the
tracer principle [98], the use of small amounts of radio-
nuclides in subjects, can be traced back to the 1920s
[99]. However, it was development of the sodium iodide
(NaI(Tl)) scintillation camera in the 1950s by Hal Anger
[100] which was the bedrock of clinical nuclear medicine
imaging systems for many decades. In the last decade
there has been significant progress made in the develop-
ment of various pre-clinical imaging systems across
many modalities, and SPECT has become one of the
principle tools [101, 102]. Several groups, including our
own, have been demonstrating the capabilities of new
SPECT system configurations [103–107]. Research
innovation in this field has been significant with devel-
opments in aspects such as image reconstruction, colli-
mation, detection, dual isotope imaging, and multimodality
systems. Small animal SPECT (and PET) systems are
exquisitely sensitive, capable of measuring picomolar
concentrations of radiolabelled biomolecules in vivo with
sub-millimetre resolution.
In terms of applications, there is considerable interest
in methods where the radiation source is inside the sub-
ject and therapeutic applications are mediated by the hu-
man sodium iodide symporter (NIS). Several groups
have evaluated the potential for the introduction of NIS
expression to support imaging and treatment for various
cancer types. For example, MSCs can be engineered to
express NIS and then home to the tumour site for deliv-
ery of therapy [108]. SPECT imaging using 123I or 99mTc
can be used to confirm the migration of the MSCs to
the tumour site, and then 131I can be used for therapy.
During the last 10–15 years, small animal radionuclide
imaging has undergone rapid technological development
and improvement in image performance metrics. Inno-
vations in several areas currently under investigation by
several groups will lead to further improvements in the
future, and radionuclide imaging will continue to play a
vital role in future molecular imaging applications. The
development of hybrid imaging with modalities such as
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• Simple, cheap, user friendly techniques
• High spatial resolution (~200 nm in x,y,) with high
sensitivity cameras
• Development of FarRed and NIR probes allow greater
tissue visualization with much less damage whilst imaging
• High sensitivity (10–12 to 10–15μm/L)
• Use of a probe generally required which may have
repercussions on stem cell physiology
• Photo-toxicity to tissue and depth resolved imaging still
an issue
• Vectors employed to introduce reporter genes are
still under scrutiny for safety and efficacy of use in
clinical trials
QPM • Accurate quantitative visualisation of phase changes
within cells
• No depth-resolving capabilities
ODT • Depth-resolving capabilities, resolution of up to 1 μm • Low penetration depth (a few hundred microns),
not suitable for real-time imaging (slow techniques)
DHM • Imaging of a 3D volume with a single exposure, structural
and phase imaging, and also flexibility for image processing.
Resolution almost as in conventional microscopy
• Relative complexity (more complicated optical set up), limitation
on coherent properties of the light source, on environmental
conditions (vibrations, etc.)
SESF and srSESF • High (nano-scale, ~10 nm demonstrated) sensitivity to
structural alterations within object and super- resolution
imaging
• More complicated optical set up, for example for detailed
quantitative analysis of the structure an imaging spectrometer
or swept light source is needed
OCT • Improved image resolution (morphological and functional
information) of depth-resolved images
• Can be combined with other imaging techniques for
multimodal imaging
• Suitable for clinical translation
• Penetration depth is limited ~2 mm into tissue
• Spatial resolution is typically limited to ~10 μm, making
this technique unsuitable for cell imaging
• Limited molecular sensitivity of tissue
OCM • Enhanced penetration depth compared to standard
confocal microscopy; dramatically improved resolution
over OCT imaging (up to 1 micron)
• Small penetration depth (compared with OCT)
nsOCT • Depth-resolved images with high sensitivity (~30 nm
demonstrated experimentally)
• Resolution and penetration depth are approximately the
same as conventional OCT
OCPM • Quantitative phase information with high sensitivity,
useful for 3D intracellular imaging
• Small depth of field
PAI • Capable of collecting molecular and spatial information
from the tissue using endogenous contrast alone
• Greater sensitivity than OCT and confocal imaging
• Suitable for clinical translation
• The ratio of the imaging depth to the best spatial
resolution is roughly a constant of 200
• Sometimes requires the use of biocompatible labelling materials




• High spatial resolution images achievable
(diffraction limited ~200 nm)
• Can work in combination with other modes of
microscopy including fluorescence and OCT
• Lack of specific light reflecting probes for confocal




• Images created have a higher spatial resolution that
normal diffraction limited techniques. (STED x.y
resolution ~20–100 nm, PALM and STORM x.y ~20–50 nm)
• Increased localization and clarity of intracellular structures
due to increased resolution
• Fluorophores or fluorescent markers must be used. Potential
for photo bleaching of the sample under study
• Expensive equipment
• Currently most super resolution techniques are not suitable
for live cell imaging
• Refractive index variations in the substrate can cause




• Can generate defined structural images with increased
all round resolution (100 μm in x,y and z dimensions)
• Suitable for clinical translation
• Exposure to ionizing radiation which can cause DNA damage
• Not suitable for soft tissues
Radionuclide
imaging
• Only low doses of labels need to be employed due
to the high sensitivity of the probes
• Good tissue penetration of the probe
• Suitable for clinical translation
• Fair sensitivity (10–8 to 10–9μm/L)
• Exposure to ionizing radiation which can cause DNA damage
• Half-life of the probe must be considered
3D three-dimensional, DHM digital holographic microscopy, NIR near infrared, nsOCT, OCPM, OCT optical coherence tomography, OCM optical coherence
microscope, ODT, PAI photoacoustic imaging, PALM photo-activated localization microscopy, QPM quantitative phase microscopy, SESF spectral encoding of the
spatial frequency, srSESF, STED stimulated emission depletion, STORM stochastic optical reconstruction microscopy, nsOCT nano-sensitive optical coherence
tomography, OCPM optical coherence phase microscopy, ODT optical doppler tomography, srSESF super-resolution spectral encoding of spatial frequency
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PET/CT, PET/MR, SPECT/CT, and, possibly in the near
future, SPECT/MR will enable biologists to observe pro-
cesses in varying time windows from minutes to weeks.
Stem cell tracking requires high spatial resolution and
sensitivity. Given that each imaging technique presents
its unique set of advantages and disadvantages, the selec-
tion of an appropriate imaging modality depends on the
application, the goal of the experiment, the subject
under study, and so forth. No imaging technique is per-
fect in all aspects. Optical imaging techniques offer
many distinctive advantages such as non-invasiveness,
resolution, high spatial and temporal sensitivity, and
adaptability, but these techniques are limited by rela-
tively poor tissue depth. Radionuclide imaging has a fair
sensitivity (10–8 to 10–9 μm/L), but it is not suitable for
long-term cell tracking due to radioisotope decay. Fluor-
escence imaging has very high sensitivity (10–12 to 10–15
μm/L), but this technique is constrained by relatively
shallow tissue depth [17]. An overview of the advantages
and disadvantages of each technique is presented in
Table 2.
Future directions should focus on multimodality im-
aging approaches that can combine the strength of each
modality for a comprehensive detection and minimise
potential drawbacks of using the imaging technique
alone. Developing biodegradable contrast agents and
multimodal contrast agents is another future develop-
ment direction. The cytotoxicity and potential toxicity
can be effectively reduced using degradable contrast
agents by facilitating the clearance of the contrast mate-
rials [109]. Future directions of microscopic-related
technologies will more than likely be in parallel with the
development of advanced label-free imaging techniques
and those which employ non-toxic cellular contrasting
agents. Future development of imaging modalities for
stem cell study should be focused on specific needs
for different applications, but all applications would
benefit from increased resolution, sensitivity, and re-
duced toxicity.
Conclusions
The vast array of technologies discussed above that are
available to clinical and scientific researchers in the field
of regenerative medicine allow multiple different eluci-
dating conclusions to be drawn from imaging or ana-
lysing the tissue under study. The development of
multimodal techniques which have the capacity to em-
ploy more sensitive, accurate, and less toxic labels to
image deeper into the innate tissue in vivo will in time
greatly further discoveries in this field. In relation to
stem cell tracking for regenerative medicine, the avail-
ability of imaging systems (combination of hardware and
cell-labelling strategy) will determine the cell-labelling
strategy, with each approach having advantages and
disadvantages. In general, the ideal system should have
high spatial (ability to resolve single cells) and temporal
resolution, contrast, sensitivity (detect small numbers of
cells), be relatively easy of use, and be inexpensive. No
imaging strategy will tick all the boxes; however, the
current trend towards multimodal imaging can exploit
one system’s advantages while negating the disadvan-
tages of another.
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